Trial Profile
Post Marketing Surveillance on the Efficacy, Safety and Tolerability of Linezolid (Zyvox) in the Treatment of Gram Positive Infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2012
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Linezolid (Primary)
- Indications Gram-positive infections
- Focus Adverse reactions
- Sponsors Pfizer
- 31 Mar 2012 New trial record